[Hemolytic-uremic syndrome. Review and new pathogenetic aspects].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001803:Blood Transfusion; D002675:Child, Preschool; D003937:Diagnosis, Differential; D004573:Electrolytes / Q000627:therapeutic use; D004912:Erythrocytes / Q000187:drug effects; D005455:Fluorescent Antibody Technique; D006463:Hemolytic-Uremic Syndrome / Q000175:diagnosis / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007668:Kidney / Q000473:pathology; D009439:Neuraminidase / Q000009:adverse effects / Q000097:blood; D011379:Prognosis; D006435:Renal Dialysis
D000900:Anti-Bacterial Agents; D004573:Electrolytes; D006493:Heparin; D009439:Neuraminidase
Hämolytisch-urämisches Syndrom. Uberblick und neue pathogenetische Aspekte